7.3 Shielding, Collimation & Gonadal Protection

Restricting and Filtering the Beam

After exposure factors, the next layer of patient protection shapes and cleans the beam before it reaches tissue.

Filtration

Filtration removes the low-energy (soft) photons that would otherwise be absorbed in the patient's skin without ever reaching the receptor — they add dose but no image. Total filtration is the sum of inherent filtration (the glass envelope, insulating oil, and window, about 0.5 mm Al equivalent) and added filtration (aluminum sheets plus the collimator mirror, about 2.0 mm Al). The regulatory minimum total filtration is 2.5 mm aluminum (Al) equivalent for tubes operated above 70 kVp (1.5 mm Al for 50–70 kVp; 0.5 mm Al below 50 kVp). Filtration hardens the beam — raising its average energy and its half-value layer (HVL) — which lowers entrance skin exposure. Compensating filters (wedge or trough shapes, e.g., for the AP thoracic spine or AP foot) even out density across anatomy of unequal thickness and reduce dose to the thinner portion.

Collimation and Beam Restriction

Collimation restricts the size of the primary beam to the anatomy of interest. Its dose benefits are twofold: a smaller field irradiates a smaller tissue volume (lower integral dose) and produces less scatter, which simultaneously improves contrast. Positive beam limitation (PBL) automatically collimates the field to the selected receptor size. Two rules matter for the exam: never collimate the field larger than the receptor, and remember that anatomy collimated out of the field cannot be recovered by post-processing — over-collimating clinically relevant anatomy forces a repeat, which increases total dose. Close collimation is one of the most effective single dose-reduction actions available at the console, and it delivers a rare double win — lower dose and higher contrast — because the scatter it eliminates would otherwise fog the image. The practical target is to include all required anatomy plus a small margin, and to see the collimation borders (four unexposed edges) on the finished image as evidence the beam was restricted. Restricting the field also reduces the workload on digital histogram analysis, since a clean, well-collimated field with predictable data helps the processing algorithm select the correct look-up table.

Contact, Shaped, and Shadow Shielding

Gonadal and specific-area shields historically blocked primary and scattered radiation from reaching radiosensitive tissue:

The classic teaching: use gonadal shielding when the gonads lie within about 5 cm (2 in) of the primary beam, when it will not obscure anatomy of interest, and after correct patient positioning. Males benefit more than females because the testes are superficial — proper shielding can cut gonadal dose by 90–95% in males and roughly 50% in females.

The Shift Away from Routine Gonadal and Fetal Shielding

This is the single most important 2020s-era update on the ARRT. In 2019 the American Association of Physicists in Medicine (AAPM) recommended discontinuing routine gonadal and fetal shielding for most diagnostic x-ray exams, a position endorsed by the ACR, ASRT, and Image Gently. The reasons: (1) contact shields frequently land over the wrong spot, obscuring anatomy and forcing repeats; (2) a shield over or near the AEC chamber causes the system to run longer and raise dose; (3) shields can trigger digital histogram (segmentation) errors; and (4) modern doses are so low that the estimated heritable/genetic risk is negligible, with no measurable population genetic effect. Many facilities now shield only on patient request or in specific circumstances. Candidates should know both frameworks: traditional shielding rules still appear on the exam, but so does the newer guidance to de-emphasize routine gonadal/fetal shielding.

Specific-Area Shielding: Breast, Thyroid, and Lens

Beyond the gonads, several superficial organs are highly radiosensitive and, when they cannot simply be positioned out of the beam, may be protected with contact or clear-lead shields. The thyroid and female breasts are protected during procedures such as scoliosis surveys or cervical-spine work when they fall near the field; the lens of the eye — a deterministic-effect (cataract) target — is spared during skull and sinus work by choosing projections that keep the beam off the orbits (for example, a PA Caldwell rather than an AP). The same 5-cm/anatomy-of-interest logic that governs gonadal shields applies here, and the same post-2019 caution about shields interfering with AEC and digital histograms applies as well; where a shield would compromise the study, positioning and collimation are preferred.

Positioning to Reduce Dose

Projection choice is itself a protection tool. Positioning the radiosensitive organ away from the entrance side of the beam lowers its dose because tissue attenuates the beam as it passes through. A PA (rather than AP) projection places the breasts, thyroid, and gonads on the exit side, cutting their dose substantially — the reason a PA full-spine scoliosis survey is preferred, markedly reducing breast and thyroid dose over an AP survey. The same logic favors a PA Caldwell for sinuses to spare the lens of the eye. A worked contrast: an AP cervical-spine or scoliosis projection irradiates the thyroid and breasts on the entrance side at full beam intensity, whereas the PA version lets several centimeters of tissue attenuate the beam before it reaches those organs — a free dose reduction that changes nothing about image quality. Combined with tight collimation and adequate filtration, projection selection completes the patient-side protection toolkit and frequently outperforms adding a physical shield.